摘要
目的调查与分析本院儿科门诊患者雾化吸入药使用情况,促进本院雾化吸入用药的规范化和合理化。方法采用回顾性分析,收集本院2016年78月儿科门诊应用雾化吸入药的处方共3919张,统计处方中患者年龄、临床诊断、雾化吸入药品种、联合用药情况,并结合药品说明书和相关文献,评价用药合理性。结果使用频率前4位的雾化吸入药分别是布地奈德混悬液、异丙托溴铵溶液、硫酸特布他林雾化液、硫酸沙丁胺醇雾化液,用药相符率分别为:90.56%、83.93%、84.47%、85.52%。病种主要以急性支气管炎、喘息性支气管炎、支气管肺炎为主。结论本院儿科门诊雾化吸入药存在一定不合理使用情况,需进一步改进。
Objective To investigate the present use of aerosol inhalation drugs in pediatric out-patients of our hospital,and to promote rational use of drugs in clinical practice.Method A total of 3919 prescriptions which contained aerosol inhalation were selected in pediatric out-patient of our hospital from July to August 2016 to conduct retrospective analysis.Results The Budesonide suspension,Ipratropium Bromide solution,Terbutaline Sulphate solution,and Salbutamol Sulphate solution were the first fourth used aerosol inhalation drugs in pediatric out-patients,while the coincidence rate of patients’indications to drug instructions were 90.56%,83.93%,84.47%,and 85.52%,respectively.The aerosol inhalation drugs were mainly used for acute bronchitis,asthmatic bronchitis,bronchopneumonia and so on.Conclusion The application status of aerosol inhalation drugs exists unreasonable phenomena,which needs further improvement.
作者
刘永谦
朱文思
林建昌
刘付伟清
Liu Yongqian;Zhu Wensi;Lin Jianchang;Liufu Weiqing(Guangdong Women and Children Hospital,Guangzhou 510010,China)
出处
《国际医药卫生导报》
2019年第24期4083-4085,共3页
International Medicine and Health Guidance News
关键词
雾化吸入
合理用药
分析
Aerosol inhalation
Rational drug use
Analysis
